ProQomics is pioneering high-throughput proteoform quantitation through a cutting-edge mass spectrometry platform. Our technology is designed to provide accurate, large-scale quantification of proteoforms and post-translationally modified proteins, empowering researchers and pharmaceutical companies to gain deeper insights into the molecular mechanisms of diseases. By combining multiplexed immuno arrays with high-resolution mass spectrometry, ProQomics enables faster, more detailed protein profiling—critical for drug discovery and biomarker development. Our products include innovative reagents, internal standards, and front-end instruments that streamline proteomics workflows, transforming how proteoforms are analyzed in research and industry.

ProQomics

Similar companies